Biogen Income Statement (2009-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Revenue & cost
Revenue (Quarter)	2,778.90M	2,733.80M	2,531.80M	2,589.10M	2,508.50M	2,544.00M	2,463.00M	2,456.00M	2,530.30M	2,386.30M	2,290.50M	2,464.90M	2,465.80M	2,454.70M	2,431.00M	2,645.50M	2,534.70M	2,279.40M	2,477.80M	2,736.00M
Cost of Revenue (Quarter)	511.80M	164.00M	275.00M	484.00M	469.50M	164.00M	662.80M	592.70M	659.60M	164.00M	542.20M	546.00M	638.70M	583.50M	629.30M	605.00M	674.40M	495.50M	661.00M	776.90M
Gross Profit (Quarter)	2,267.10M	2,569.80M	2,256.80M	2,105.10M	2,039.00M	2,380.00M	1,800.20M	1,863.30M	1,870.70M	2,222.30M	1,748.30M	1,918.90M	1,827.10M	1,871.20M	1,801.70M	2,040.50M	1,860.30M	1,783.90M	1,816.80M	1,959.10M
Operating items
Amortization - Intangibles (Quarter)	111.00M	68.10M	66.90M	67.50M	56.50M	175.00M	50.20M	52.90M	60.90M	76.60M	78.30M	86.90M	130.30M	151.20M	111.80M	130.90M	135.70M	136.60M	136.50M	168.20M
Research & Development (Quarter)	702.40M	699.50M	551.70M	528.60M	549.20M	601.60M	570.60M	584.20M	736.30M	75.00M	445.40M	505.40M	516.20M	513.30M	434.10M	399.00M	436.10M	509.40M	539.00M	529.60M
Selling, General & Administrative (Quarter)	654.10M	787.90M	634.90M	572.60M	563.30M	632.80M	605.00M	548.00M	788.20M	608.50M	581.50M	553.80M	588.40M	680.00M	572.50M	583.80M	594.80M	682.50M	607.30M	709.70M
Restructuring Costs (Quarter)			27.70M	900.00M	7.10M	7.00M	7.10M	17.80M	11.50M	98.80M	11.50M	6.60M	6.80M	5.30M	35.30M	-0.70M	7.40M	6.60M	7.90M	165.40M
Other Operating Expenses (Quarter)	-502.90M	964.10M	-263.30M	428.60M	503.70M	-165.30M	-69.40M	121.20M	-300.00M	248.20M	-93.70M	88.60M	-14.80M	282.30M	-68.40M	-48.70M	-34.10M	117.60M	-19.70M	-18.50M
Operating Expenses (Quarter)	2,487.80M	2,328.80M	2,184.40M	1,319.60M	1,137.40M	1,940.20M	2,024.70M	1,747.90M	2,671.50M	2,094.70M	1,825.70M	1,766.20M	2,014.80M	2,163.20M	2,119.80M	1,901.50M	1,977.40M	2,335.40M	2,100.10M	2,603.60M
Operating Income (Quarter)	794.00M	587.10M	610.70M	785.50M	901.60M	439.80M	-224.50M	115.40M	-800.80M	127.60M	-77.40M	152.70M	-187.70M	-292.00M	-318.10M	139.00M	-117.10M	-551.50M	-283.30M	-644.50M
EBIT (Quarter)	794.00M	587.10M	610.70M	785.50M	901.60M	439.80M	-224.50M	115.40M	-800.80M	127.60M	-77.40M	152.70M	-187.70M	-292.00M	-318.10M	139.00M	-117.10M	-551.50M	-283.30M	-644.50M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	-502.90M	-182.10M	-263.30M
Net income details
EBT (Quarter)	291.10M	405.00M	347.40M	1,269.50M	1,371.10M	603.80M	438.30M	708.10M	-141.20M	291.60M	464.80M	698.70M	451.00M	291.50M	311.20M	744.00M	557.30M	-56.00M	377.70M	132.40M
Tax Provisions (Quarter)	-25.90M	443.20M	125.60M	216.70M	236.20M	54.30M	50.70M	114.80M	-72.90M	42.70M	71.40M	115.10M	62.50M	24.80M	70.70M	109.20M	90.80M	-7.10M	58.20M	34.90M
Profit After Tax (Quarter)	329.20M	-20.50M	303.80M	1,058.70M	1,134.90M	550.40M	387.90M	593.30M	-68.30M	248.90M	393.40M	583.60M	388.50M	266.70M	240.50M	634.80M	466.50M	-48.90M	319.50M	97.50M
Income from Non-Controlling Interests (Quarter)	-11.10M	-388.70M	-85.30M	0.70M	0.20M	-0.90M	-0.30M	1.70M	-0.20M	-0.80M
Income from Continuing Operations (Quarter)	317.00M	-38.20M	221.80M	1,052.80M	1,134.90M	549.50M	387.60M	593.30M	-68.30M	248.90M	393.40M	583.60M	388.50M	266.70M	240.50M	634.80M	466.50M	-48.90M	319.50M	97.50M
Consolidated Net Income (Quarter)	317.00M	-38.20M	221.80M	1,052.80M	1,134.90M	549.50M	387.60M	593.30M	-68.30M	248.90M	393.40M	583.60M	388.50M	266.70M	240.50M	634.80M	466.50M	-48.90M	319.50M	97.50M
Income towards Parent Company (Quarter)	317.00M	-38.20M	221.80M	1,052.80M	1,134.90M	549.50M	387.60M	593.30M	-68.30M	248.90M	393.40M	583.60M	388.50M	266.70M	240.50M	634.80M	466.50M	-48.90M	319.50M	97.50M
Net Income towards Common Stockholders (Quarter)	317.00M	-38.20M	221.80M	1,052.80M	1,134.90M	549.50M	387.60M	593.30M	-68.30M	248.90M	393.40M	583.60M	388.50M	266.70M	240.50M	634.80M	466.50M	-48.90M	319.50M	97.50M
Additional items
EPS (Basic) (Quarter)	2.14	-0.26	1.51	7.22	7.86	3.78	2.68	4.10	-0.47	1.72	2.71	4.01	2.67	1.83	1.65	4.33	3.18	-0.33	2.17	0.66
EPS (Diluted) (Quarter)	2.13	-0.26	1.50	7.20	7.84	3.76	2.67	4.08	-0.47	1.71	2.70	4.00	2.66	1.83	1.64	4.33	3.17	-0.33	2.15	0.66
Shares Outstanding (Quarter)	148.00M	149.10M	147.10M	145.90M	144.40M	145.30M	144.40M	144.70M	144.80M	144.70M	145.20M	145.60M	145.70M	145.60M	146.10M	146.50M	146.60M	146.50M	147.20M	147.70M
Shares Outstanding (Diluted) (Quarter)	148.60M	149.60M	147.60M	146.20M	144.80M	146.00M	145.20M	145.50M	144.80M	145.60M	145.90M	145.90M	146.10M	145.90M	146.60M	146.70M	147.10M	147.10M	148.40M	148.70M
Shares Outstanding (Entity) (Quarter)	170.70M	170.80M	171.30M	169.00M	167.80M	167.90M	168.60M	168.60M	168.70M	168.70M	169.40M	169.50M	169.50M	169.50M	170.30M	170.40M	170.50M	170.50M	171.40M	171.50M
EBITDA (Quarter)	794.00M	587.10M	610.70M	785.50M	901.60M	439.80M	-224.50M	115.40M	-800.80M	127.60M	-77.40M	152.70M	-187.70M	-292.00M	-318.10M	139.00M	-117.10M	-551.50M	-283.30M	-644.50M
Interest Expenses (Quarter)	195.00M	66.30M	85.00M	180.00M	175.00M	54.80M	85.00M	170.00M	435.00M	71.50M	710.00M	710.00M	615.00M	60.00M	665.00M	665.00M	580.00M	67.50M	650.00M	925.00M
Tax Rate (Quarter)	-8.90%	109.43%	36.15%	17.07%	17.23%	8.99%	11.57%	16.21%	51.63%	14.64%	15.36%	16.47%	13.86%	8.51%	22.72%	14.68%	16.29%	12.68%	15.41%	26.36%

Research Tools

Datasets

Plans

Developers

Biogen BIIB Income Statement (2009-2026)

Research Tools

Datasets

Plans

Developers

Biogen BIIB Income Statement (2009-2026)

Create an account

Sign In

Reset Password